Pharma & Biotech News , from our Global Correspondents
Refine Search
Pharmaceutical
The Russian government has decided to allocate additional funding for the purchases of some vital, imported drugs, which are not produced in the country, amid fears of their potential shortage in the local market, according to recent statements made by an official spokesman of the Russian Ministry of Health as well as some industry’s analysts, reports The Pharma Letter’s local correspondent. 10 September 2019
Pharmaceutical
The Russian government has announced its plans to increase state funding for the purchases of orphan drugs and create conditions for the beginning of their production within the country, according to recent statements from the state press-service, reports The Pharma Letter’s local correspondent. 2 September 2019
Generics
The disputes between manufacturers of original drugs and their Russian rivals may have a new twist in the local market, as the Russian Supreme Court has supported AstraZeneca in its legal fight with Jodas Expoim – a Russian subsidiary of Indian firm Jodas Expoim Pvt Ltd – by the ordering withdrawal of the certificate for its generic copy of Iressa (gefitinib), reports The Pharma Letter’s local correspondent. 2 September 2019
Pharmaceutical
By Dr Nicola Davies
September 7th is World Duchenne Awareness Day and the perfect opportunity to delve into the details of Duchenne muscular dystrophy (DMD) and pharma’s role in helping individuals living with this condition. 30 August 2019
Generics
Even as the Health Ministry is slated to exempt a popular contraceptive fixed dose combination (FDC) of centchroman and ethinyloestradiol from the Schedule H category (which has drugs that cannot be purchased over the counter without a valid prescription), a Central Drugs Standard Control Organization (CDSCO) expert committee is looking to further ban another lot of 324 FDCs, reports The Pharma Letter’s India correspondent. 30 August 2019
Pharmaceutical
With this being what in the news industry is called ‘the silly season’ – ie, lack of solid news, our long term Japan watcher P Reed Maurer has come up with some thoughts on the local pharmaceutical industry. These are not facts, just fantasy speculation, but certainly something worth thinking about. Hope you, our readers, enjoy this as much as I did. Barbara Obstoj-Cardwell. Editor. 24 August 2019
Pharmaceutical
Walk into any pharma company office in Japan and you will most likely see a plaque on a wall outlining the company’s mission. One of the statements will say: “Everything we do is to benefit patients,” notes long-time Japan pharma watcher and president of International Alliances Limited P Reed Maurer in his exclusive column for The Pharma Letter. 20 August 2019
Pharmaceutical
Even as the world's largest vaccine manufacturer by volume of doses Serum Institute of India and the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, have teamed up to create the first ever heat-stable rotavirus vaccine, many states in India have launched vaccination drives against rotavirus infections, a significant driver of child mortality in India, reports The Pharma Letter’s local correspondent. 19 August 2019
Pharmaceutical
The Delhi High Court has allowed Alembic Pharmaceuticals and Natco Pharma to export sorafenib, an active ingredient in German pharma major Bayer’s cancer drug Nexavar, and rivaroxaban, the API in its blood thinner medicine Xarelto, for research and development purposes. 19 August 2019
Pharmaceutical
Ensuring that the actions, messages and objectives of pharma companies and representative national and regional associations are aligned with the needs of patients and health systems in Latin America. 16 August 2019
Pharmaceutical
By Dr Nicola Davies
Labeling information, including product inserts, are important components of marketed drug products. Clear and complete labeling information is critical for both health professionals and patients to make informed decisions. It also ensures consumers are aware of the correct use of these medications to maintain safety and achieve the intended effectiveness. The importance of appropriate labeling information is highlighted by the US Food and Drug Administration’s recent actions to optimize labeling content for prescription drugs, including biologicals. 13 August 2019
Generics
Russian drugmaker R-Pharm is expanding its line of generics of original drugs by starting production of an analogue of Sevoran (sevoflurane), which is an anesthetic produced by the US biopharma company AbbVie. 13 August 2019
Pharmaceutical
Russian hospitals may face with a shortage of some vital and other drugs this year, due to massive disruptions in public procurements, according to recent statements by representatives of hospitals, reports The Pharma Letter’s local correspondent. 13 August 2019
Pharmaceutical
The Russian pharmaceutical market may face a steep decline in the second half of the current year, due to the ongoing slumping of drug sales in the country, according to recent statements by some senior state officials and industry’s analysts, reports The Pharma Letter’s local correspondent. 6 August 2019
Generics
The Russian government plans to accelerate its efforts aimed at raising exports of domestic drugs and active ingredients by 2030, reports The Pharma Letter’s local correspondent. 6 August 2019
Pharmaceutical
The National List of Essential Medicines (NLEM) in India, which determines the basis of drug price regulation, is set to add new medicines for the treatment of cardiac diseases and cancer along with certain antibiotics to its list. This would result in a massive slash in prices for these drugs, reports The Pharma Letter’s India correspondent. 1 August 2019
Biotechnology
Russian drugmaker Biocad is expanding into the therapeutic area of psoriatic drugs, through the launch of production of its new treatment Efleira (netakimab), according to recent statements by the company, reports The Pharma Letter’s local correspondent. 29 July 2019
Pharmaceutical
Russia may become the world’s first country that will have its own production of a drug for the treatment of hepatitis Delta, according to recent statements by Pavel Bogomolov, head of the Department of Hepatology at Moscow Vladimirsky Regional Research Clinical Institute. 29 July 2019
Generics
Global drugmakers may find it easier to reach amicable agreements with their Russian rivals over patent disputes for their drugs in the local market, mainly due to a recent agreement, reached between Russian drugmaker Pharmasyntez and the Argentinian firm Laboratorio Tuteur in the patent dispute between the companies. 23 July 2019
Pharmaceutical
The Russian government is considering easing the existing restrictions on the participation of foreign drugmakers during public procurements in the domestic market, according to recent statements of some sources close to the Russian Ministry of Health and industry analysts, reports The Pharma Letter’s local correspondent. 23 July 2019
Pharmaceutical
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Generics
The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related with the overall reduction of investment activities in the local pharmaceutical market, reports The Pharma Letter’s local correspondent. 30 September 2024
Pharmaceutical
Pharmaceutical laboratories, institutions, guilds and medical federations have taken on the task of designing programs to end health illiteracy in order to have informed, educated, knowledgeable and empowered communities where their health and wellbeing are concerned. 19 September 2024
Pharmaceutical
Oligonucleotide therapeutics are rapidly emerging as a promising class of drugs capable of addressing a variety of genetic and complex diseases by targeting RNA sequences.1 16 September 2024
Generics
The protection of intellectual property (IP) rights of foreign pharmaceutical companies in Russia remains complex situation, according to recent statements by Konstantin Panurovsky, legal director of AstraZeneca’s Russian subsidiary, reports The Pharma Letter’s local correspondent. 13 September 2024
Pharmaceutical
The Russian Ministry of Health wants to speed registration of drugs that are not localized in the Russian Federation at the time of the application submitted by domestic pharmaceutical companies, explaining such changes by "unpredictable geopolitical situation," reports The Pharma Letter’s local correspondent. 12 September 2024
Biotechnology
NewCo, a relatively new business model that involves a joint venture (JV) between a biotech and a group of investors to bring the biotech’s promising assets to the global market, is gaining popularity among Chinese biotechs, who traditionally rely on out-licensing deals to capitalize assets, s 11 September 2024
Generics
A significant drop has been noticed in the prices of active pharmaceutical ingredients (APIs), bringing much-needed relief to the pharmaceutical industry and potentially translating to lower drug costs for consumers. 9 September 2024
Biotechnology
Targeted alpha therapy (TAT), or radioligand therapy, is a recent hot area that attracted big pharmas like Bristol Myers Squibb and Novartis. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Pharmaceutical
Scientists from the Russian Institute of Immunology of the Federal Medical and Biological Agency (FMBA) say they have created the world's first allergy vaccine. 30 August 2024
Generics
In a major crackdown, the Indian government has imposed an immediate ban on 156 fixed-dose combination (FDC) drugs, including commonly used antibiotics, pain relievers,and multivitamins. 27 August 2024
Pharmaceutical
Russia plans to create conditions for a significant increase of domestic production of anti-Rhesus immunoglobulin drugs after a sharp decrease of their imports to the local market this year, reports The Pharma Letter’s local correspondent. 22 August 2024
Generics
One of the largest pharmaceutical production facilities in the Russian North-West region will soon be built in the city of Pushkino by the local drugmaker Active Component enterprise, The Pharma Letter’s local correspondent reports. 14 August 2024
Pharmaceutical
The shortage of drugs in Russia is deepening, and is currently being observed in almost 70 regions throughout the country and forcing the local state to consider ways to resume stable supplies to local market, reports The Pharma Letter’s local correspondent. 13 August 2024
Generics
The Russian Ministry of Health has registered the third Russian generic of the original drug Ozempic (semaglutide) from Danish drugmaker Novo Nordisk. 8 August 2024
Generics
US biotech major Biogen is disputing the launch of a Russian generic of Spinraza (nusinersen), a drug, which is used to treat spinal muscular atrophy (SMA), reports The Pharma Letter’s local correspondent. 7 August 2024
Pharmaceutical
Domestic drugs and foreign drugs, the production of which is localized in Russia, will be given a priority when included in the list of vital and essential drugs (VED) and expensive drugs, according to a recent resolution signed by the Russian government, The Pharma Letter’s local correspondent reports. 1 August 2024
Pharmaceutical
Major pharmaceutical multinationals are looking to collaborate with Indian drug firms, leveraging their cost-efficient manufacturing capabilities, robust supply chains, and innovative research potential. 31 July 2024
Pharmaceutical
The Russian government will be ready to significantly increase state procurements of drugs against hepatitis C in case of reduction price for them both by global drugmakers and Russian pharmaceutical companies. 31 July 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze